The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
Abstract
Objective : To determine the efficacy of antiplatelet therapy as prophylaxis against deep venous thrombosis or pulmonary embolism in surgical and high risk medical patients. Design : Overviews of all randomised trials of antiplatelet therapy that could have been available by March 1990 and in which deep venous thrombosis was assessed systematically. Setting : 53 trials (total 8400 patients) of an average of two weeks of antiplatelet therapy versus control in general or orthopaedic surgery; nine trials (600 patients) of antiplatelet therapy versus control in other types of immobility; 18 trials (1000 patients) of one antiplatelet regimen versus another. Results : Overall, a few weeks of antiplatelet therapy produced a highly significant (2P < 0.00001) reduction in deep venous thrombosis. 25% of patients allocated antiplatelet therapy versus 34% of appropriately adjusted controls had deep venous thrombosis detected by systematic fibrinogen scanning or venography, representing prevention in about 90 patients per 1000 allocated antiplatelet therapy. There was an even greater proportional reduction in pulmonary embolism: such emboli were detected among 47 (1.0%) antiplatelet allocated patients versus an adjusted control total of 129 (2.7%), representing prevention among about 17 patients per 1000 treated (2P < 0.00001). In analyses confined to surgical trials, the proportional reductions were similar and separately significant for nonfatal pulmonary embolism (0.7% antiplatelet therapy upsilion 1.8% control; 2P < 0.00001) and for deaths attributed to pulmonary embolism (0.2% upsilion 0.9%; 2P = 0.0001). There was a slight but non - significant excess of deaths from other causes (1.0% upsilion 0.7%), which made the difference in total mortality non-significant, though still favourable (1.2% upsilion 1.5%). Information on adding antiplatelet therapy to heparin was limited but, at least for pulmonary embolism, suggested more protection from the combination than from heparin alone. Conclusion : It had previously been supposed that antiplatelet therapy did not influence venous thromboembolism, and many surgeons and physicians do not use it routinely for thromboprophylaxis, even for patients who are at substantial risk of deep venous thrombosis or pulmonary embolism. These results indicate that antiplatelet therapy - either alone or, for greater effect, in addition to other proved forms of thromboprophylaxis (such as subcutaneous heparin) - should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Antiplatelet Trialists' Collaboration (1988) · BMJ · doi:10.1136/bmj.296.6618.320 · Cited by 1,047
Efron, B., & Morris, C. (1977) · Scientific American · doi:10.1038/scientificamerican0577-119 · Cited by 739
Prevention of Venous Thrombosis and Pulmonary Embolism
(1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380060070028 · Cited by 460
Aspirin Prophylaxis of Venous Thromboembolism after Total Hip Replacement
Harris, W. H., Salzman, E. W., Athanasoulis, C. A., Waltman, A. C., & DeSanctis, R. W. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712082972302 · Cited by 344
Prevention of venous thrombosis and pulmonary embolism
Kakkar, V. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90116-i · Cited by 310
Postoperative Pulmonary Embolism After Hospital Discharge: An Underestimated Risk
Huber, O. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420030076014 · Cited by 273
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
A 30-year survey of pulmonary embolism verified at autopsy: An analysis of 1274 surgical patients
Bergqvist, D., & Lindblad, B. (1985) · Journal of British Surgery · doi:10.1002/bjs.1800720211 · Cited by 196
McKenna, R., Galante, J. O., Bachmann, F., Wallace, D. L., Kaushal, P. S., & Meredith, P. (1980) · BMJ · doi:10.1136/bmj.280.6213.514 · Cited by 192
Collins, R., Gray, R., Godwin, J., & Peto, R. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060308 · Cited by 178
Carter, A. E., & Eban, R. E. (1974) · BMJ · doi:10.1136/bmj.3.5923.94 · Cited by 87
Lensing, A. W. A., & Hirsh, J. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651177 · Cited by 82
Morris, G. K., & Mitchell, J. R. A. (1977) · BMJ · doi:10.1136/bmj.1.6060.535 · Cited by 79
Prevention of Postoperative Deep Venous Thrombosis and Pulmonary Embolism
Carter, A. E., Eban, R. E., & Perrett, R. D. (1971) · BMJ · doi:10.1136/bmj.1.5744.312 · Cited by 71
Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report
Chrisman, O. D., Snook, G. A., Wilson, T., & Short, J. (1976) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197658070-00003 · Cited by 47
Thromboembolism After Surgical Treatment of Hip Fractures
Snook, G. A., Chrisman, O. D., & WILSON, T. C. (1981) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198103000-00003 · Cited by 46
Gent, M., & Roberts, R. S. (1986) · CHEST Journal · doi:10.1378/chest.89.5_supplement.396s · Cited by 41
Aspirin-Sulfinpyrazone in Prophylaxis of Deep Venous Thrombosis in Total Hip Replacement
Sautter, R. D., Koch, E. L., Myers, W. O., Ray, J. R., Mazza, J. J., Larson, D. L., Chen, H. M., Milbauer, J. P., Treuhaft, P. S., & Plotka, E. D. (1983) · JAMA · doi:10.1001/jama.1983.03340190051031 · Cited by 36
Alfaro, M. J., Páramo, J. A., & Rocha, E. A. V. (1986) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661602 · Cited by 35
Cooke, E., Dawson, M., Ibbotson, R. M., Bowcock, S., Ainsworth, M., & Pilcher, M. F. (1977) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197759040-00013 · Cited by 28
Hansen, E., Jessing, P., Lindewald, H., Østergaard, P., Olesen, T., & Malver, E. (1976) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-197658080-00008 · Cited by 27
Prevention of postoperative thrombosis by aspirin
Hume, M., Bierbaum, B., Kuriakose, T. X., & Surprenant, J. (1977) · The American Journal of Surgery · doi:10.1016/0002-9610(77)90125-8 · Cited by 17
McBride, J. A., Turpie, A. G. G., Kraus, V., & Hiltz, C. (1975) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1689350 · Cited by 9
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Metadata
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-01-22
- Volume
- 308
- Issue
- 6923
- Pages
- 235-246
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W4249374822
- Cited by
- 531
- References
- 27
- FWCI
- 23.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.